Unique specialty catheter designed for enhancing efficiency in
complex interventional procedures – builds on Vascular Solutions’
popular GuideLiner® Catheter platform by
combining the features of a guide extension catheter with new guidewire
trapping capabilities in a single device.

February 22, 2017 06:00 PM Eastern Daylight Time

WAYNE, Pa.--(EON: Enhanced Online News)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care and surgery, has announced 510(k)
clearance by the Food and Drug Administration and US commercial launch
of the TrapLiner Catheter.

“The TrapLiner is a one-of-a-kind product that combines two devices we
had previously deployed independently during challenging cases into a
single tool that enables the most complicated interventional procedures
to be done more efficiently”

The TrapLiner Catheter was developed by Vascular Solutions, Inc., which
was acquired by Teleflex on February 17, 2017.

The TrapLiner Catheter is similar in design to Vascular Solutions’
popular GuideLiner Guide Extension Catheter, with the added feature of
an integrated balloon for trapping a standard 0.014” guidewire within a
guide catheter. The TrapLiner Catheter can be used as an alternative
method to the trapping technique that requires the use of a PTCA balloon
to exchange an existing over-the-wire catheter while maintaining
guidewire position. The technique of guidewire trapping for catheter
exchange is most commonly performed in complex interventional
procedures. The device is offered in three different sizes: 6, 7, and 8
Fr.

“The TrapLiner is a one-of-a-kind product that combines two devices we
had previously deployed independently during challenging cases into a
single tool that enables the most complicated interventional procedures
to be done more efficiently,” said Dimitri Karmpaliotis, MD, PhD,
Director of CTO, Complex and High-Risk Angioplasty at Columbia
University Medical Center, who was the first to use the device in the
United States. “The primary clinical use for the TrapLiner is during
cases in which over-the-wire microcatheters are required to cross
calcified lesions, navigate bifurcations, or cross tortuous anatomy.
During these procedures, the TrapLiner not only provides added backup
support and deep-seating for the guide catheter, but also allows the
operator to maintain guidewire positioning when exchanging the
microcatheter. The distinct two-in-one capability of this device is
highly desirable, as it greatly enhances the efficiency of complex
procedures.”

The TrapLiner Catheter is intended for use in conjunction with guide
catheters to access discrete regions of the coronary and/or peripheral
vasculature, to facilitate placement of interventional devices, and to
facilitate the exchange of an interventional device while maintaining
the position of the guidewire within the vasculature.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs - to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® - trusted brands united by a common sense of
purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.

GuideLiner and TrapLiner are trademarks or registered trademarks of
Vascular Solutions, Inc.